SK Bioscience Return On Asset vs. Operating Margin

302440 Stock   46,550  600.00  1.27%   
Based on the measurements of profitability obtained from SK Bioscience's financial statements, SK Bioscience Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess SK Bioscience's ability to earn profits and add value for shareholders.
For SK Bioscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SK Bioscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SK Bioscience Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SK Bioscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SK Bioscience Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between SK Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if SK Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SK Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

SK Bioscience Operating Margin vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining SK Bioscience's current stock value. Our valuation model uses many indicators to compare SK Bioscience value to that of its competitors to determine the firm's financial worth.
SK Bioscience Co is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers reporting about  4.19  of Operating Margin per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value SK Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for SK Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

302440 Operating Margin vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

SK Bioscience

Return On Asset

 = 

Net Income

Total Assets

 = 
0.11
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

SK Bioscience

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.47 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

302440 Operating Margin Comparison

SK Bioscience is currently under evaluation in operating margin category among its peers.

302440 Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on SK Bioscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of SK Bioscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the SK Bioscience's important profitability drivers and their relationship over time.

Use SK Bioscience in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SK Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SK Bioscience will appreciate offsetting losses from the drop in the long position's value.

SK Bioscience Pair Trading

SK Bioscience Co Pair Trading Analysis

The ability to find closely correlated positions to SK Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SK Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SK Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SK Bioscience Co to buy it.
The correlation of SK Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SK Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SK Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SK Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your SK Bioscience position

In addition to having SK Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investing Thematic Idea Now

Investing
Investing Theme
Companies involved in money management and investment banking services. The Investing theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in 302440 Stock

To fully project SK Bioscience's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of SK Bioscience at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include SK Bioscience's income statement, its balance sheet, and the statement of cash flows.
Potential SK Bioscience investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although SK Bioscience investors may work on each financial statement separately, they are all related. The changes in SK Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on SK Bioscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.